序号 |
标题 |
次数 |
作者 |
发布时间 |
78571 |
PCAH-N3(叠氮基团的线形聚合物;PCAH-azide) |
111 |
WYQ |
2024-12-09 |
78572 |
DOTA-HCBP-1,多肽分子探针 |
78 |
wyh |
2024-12-09 |
78573 |
CAS号:1380006-72-3 exo BCN-O-PNB |
125 |
zyl |
2024-12-09 |
78574 |
PCH-N3(叠氮化聚碳酸酯聚合物;PCH-azide) |
109 |
WYQ |
2024-12-09 |
78575 |
NOTA-EB-RGDfK ,EB-RGD ,双功能鳌合剂NOTA偶联EB-环状多肽RGDfK |
71 |
wyh |
2024-12-09 |
78576 |
PGMA-N3(聚-3-叠氮-2-羟基-甲基丙烯酸丙酯或PGMA-azide) |
90 |
WYQ |
2024-12-09 |
78577 |
endo BCN-PEG3-NH2 环丙烷环辛炔聚乙二醇氨基 |
75 |
zyl |
2024-12-09 |
78578 |
lhb-(PLA-b-PBocAEA-N3)n-g-PEG(叠氮基团接枝聚乙二醇PEG长链超支化多嵌段共聚物) |
94 |
WYQ |
2024-12-09 |
78579 |
BCN-PEG-Rhodamine B 环丙烷环辛炔聚乙二醇罗丹明B |
168 |
zyl |
2024-12-09 |
78580 |
叠氮化的全氟辛基碘代烷(PFO-N3或PFO-azide) |
140 |
WYQ |
2024-12-09 |
78581 |
BCN-PEG-Maleimide 环丙烷环辛炔聚乙二醇马来酰亚胺 |
96 |
zyl |
2024-12-09 |
78582 |
叠氮二氢硼多聚体(H2BN3)n (n=1-4) |
170 |
WYQ |
2024-12-09 |
78583 |
金属叠氮多聚体(Me2MN3)n(n=1~3, M=Ga, Al) |
150 |
WYQ |
2024-12-09 |
78584 |
PLG-N3与3-叠氮丙胺改性聚(L-谷氨酸)-接枝-聚乙二醇单甲醚/叠氮丙胺 |
158 |
WYQ |
2024-12-09 |
78585 |
Me-Tet-PEG4-NH2 甲基四嗪-四聚乙二醇-氨基 |
107 |
zyl |
2024-12-09 |
78586 |
Methyltetrazine-PEG6-maleimide 甲基四嗪-六聚乙二醇-马来酰亚胺 |
87 |
zyl |
2024-12-09 |
78587 |
Me-Tet-PEG5-COOH , CAS:2143964-72-9 , 甲基四嗪-五聚乙二醇-羧基 |
78 |
zyl |
2024-12-09 |
78588 |
DOTA-SPIONs-PEG-FA ,超顺磁性氧化铁纳米粒子叶酸DOTA |
95 |
wyh |
2024-12-09 |
78589 |
DOTA-PEG4-YLFFVFER,双功能螯合剂DOTA偶联多肽YLFFVFER |
103 |
wyh |
2024-12-09 |
78590 |
P(VDF-TrFE)@DOTA-Gd@RGD;复合压电纳米粒子 |
112 |
wyh |
2024-12-09 |
78591 |
DOTA-Cyclo(ETSK)-SF-NH2(SETSKSF),环肽抑制剂偶联螯合剂DOTA |
98 |
wyh |
2024-12-09 |
78592 |
DOTA-SD01, DOTA偶联苄基苯并吲哚甲基吲哚化合物 |
71 |
wyh |
2024-12-09 |
78593 |
DOTA-lintuzumab,林妥珠单抗偶联DOTA双功能螯合剂 |
81 |
wyh |
2024-12-09 |
78594 |
Me-Tet-PEG8-NHBoc, CAS:2143968-21-0, 甲基四嗪-八聚乙二醇-NHBoc |
62 |
zyl |
2024-12-09 |
78595 |
Gd-DOTA-pertuzumab ,纳米探针钆特酸葡胺-帕妥珠单抗 |
112 |
wyh |
2024-12-09 |
78596 |
Nd-DOTA-Cn ,Nd-DOTA偶联姜黄素 ,Nd-DOTA-curcumin |
85 |
wyh |
2024-12-09 |
78597 |
Methyltetrazine-PEG4-aldehyde 甲基四嗪-四聚乙二醇-乙醛 |
83 |
zyl |
2024-12-09 |
78598 |
Fe3O4-PEG-DOTA NPs ,大环配体DOTA修饰性氧化铁纳米颗粒 |
72 |
wyh |
2024-12-09 |
78599 |
Me-Tet-PEG3-Maleimide, CAS:2141976-31-8, 甲基四嗪-三聚乙二醇-马来酰亚胺 |
71 |
zyl |
2024-12-09 |
78600 |
NH2-PEG-DOTA-PEG-NH2 , 氨基-聚乙二醇-DOTA-聚乙二醇-氨基 |
81 |
wyh |
2024-12-09 |
78601 |
Methyltrazine-ICG 甲基四嗪-吲哚菁绿 Me-Tet-ICG |
73 |
zyl |
2024-12-09 |
78602 |
DOTA-Cy5.5-PS ;DOTA-Cy5.5-聚苯乙烯 |
175 |
wyh |
2024-12-09 |
78603 |
Methyltetrazine-PEG12-NHS ester,2055646-25-6,甲基四嗪-十二聚乙二醇-琥珀酰亚胺酯 |
84 |
zyl |
2024-12-09 |
78604 |
Cy7.5-HER2-Nb , 荧光分子Cy7.5标记HER2纳米抗体探针 |
87 |
wyh |
2024-12-09 |
78605 |
Coumarin-PEG8-tetrazine 香豆素-八聚乙二醇-四嗪 |
152 |
zyl |
2024-12-09 |
78606 |
Tetrazine-PEG5-SS-amine 四嗪-双硫键-五聚乙二醇-氨基 |
74 |
zyl |
2024-12-09 |
78607 |
Tetrazine-Ph-NHCO-PEG3-alcohol 四嗪-Ph-NHCO-三聚乙二醇-乙醇 |
96 |
zyl |
2024-12-09 |
78608 |
钆(Gd)金属配合物,Gd-DOTA |
84 |
wyh |
2024-12-09 |
78609 |
DOTA螯合剂标记αPD-L1抗体,DOTA-Y003 3.7MBq RIT |
91 |
wyh |
2024-12-09 |
78610 |
Tetrazine-PEG7-amine hydrochloride,四嗪-七聚乙二醇-氨基盐酸盐 |
88 |
zyl |
2024-12-09 |
78611 |
PPI-MALDS-DOTA,第四代聚丙烯亚胺树状大分子修饰麦芽糖壳层偶联DOTA |
101 |
wyh |
2024-12-09 |
78612 |
cas:2123482-78-8 Tetrazine-SS-Biotin 四嗪-二硫键-生物素 |
88 |
zyl |
2024-12-09 |
78613 |
Gd-DOTA , 1,4,7,10-四乙酸-1,4,7,10-四氮杂环十二烷合钆 |
88 |
wyh |
2024-12-09 |
78614 |
(4-(1,2,4,5-Tetrazin-3-yl)phenyl)methanamine,Tetrazine-NH2,四嗪-氨基 |
78 |
zyl |
2024-12-09 |
78615 |
DOTA-PEG-GA,DOTA-聚乙二醇-GA |
95 |
wyh |
2024-12-09 |